AIM
XERS icon

Aigen Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

Aigen Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Buy
32,521
+20,259
+165% +$134K 0.05% 436
2025
Q4 		$96.3K Sell
12,262
-6,867
-36% -$54K 0.02% 517
2025
Q3 		$156K Buy
+19,129
New +$127K 0.02% 704
2025
Q2 		– Sell
-16,769
Closed -$92.1K – 1109
2025
Q1 		$92.1K Buy
+16,769
New +$67.7K 0.01% 696
2023
Q4 		– Sell
-10,384
Closed -$19.3K – 1126
2023
Q3 		$19.3K Buy
+10,384
New +$23.8K ﹤0.01% 784
2022
Q1 		– Sell
-10,586
Closed -$31K – 1148
2021
Q4 		$31K Buy
+10,586
New +$22.9K ﹤0.01% 1018

Other funds holding XERS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return